The reverse split is a compliance-driven measure that does not alter fundamentals. Monitor whether the post-split bid price sustains above $1.00 for 10 consecutive trading days to confirm Nasdaq compliance; failure to regain compliance could lead to delisting risk.
Price Chart
Executive Summary
Medicus Pharma Ltd. announced a 50-to-1 reverse share split effective October 12, 2026, to boost the bid price and regain compliance with Nasdaq's minimum bid price requirement for continued listing. The consolidation was authorized by shareholders at the June 3, 2026 annual meeting and does not change the company's name, ticker symbol, or shareholder voting power.
Key Facts
- Reverse share split ratio: 50-to-1, effective October 12, 2026.
- Purpose: to increase bid price and regain compliance with Nasdaq minimum bid price listing requirement.
- Shareholder authorization obtained at June 3, 2026 annual meeting.
- No fractional shares will be issued; fractional entitlements will be rounded down and cash paid in lieu.
- Ticker symbol MDCX and company name remain unchanged.
- Proportionate adjustments will be made to outstanding equity awards, convertible securities, and warrants.
Financial Impact
No financial figures reported; the split is a mechanical share count adjustment with no change to aggregate market cap or enterprise value.
Risk Factors
- Reverse split may not achieve sustained compliance with Nasdaq's $1.00 minimum bid price.
- Post-split share price could decline, increasing delisting risk.
- Reduced share count may decrease liquidity and increase volatility.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001062993-26-005226 |
| Document: 0001062993-26-005226-index-headers.html | 0001062993-26-005226 |
| Document: 0001062993-26-005226-index.html | 0001062993-26-005226 |
| Document: 0001062993-26-005226.txt | 0001062993-26-005226 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $2.60 | awaiting T+1 | — | $2.51 (−3.46%) |
Oct 16, 2026 10d ago | 8-K | $2.66 $2.72 | ▲ +2.45% | ▲ +2.11% | $2.51 (−5.46%) |
Oct 16, 2026 10d ago | SC 13G/A | $2.66 $2.72 | ▲ +2.45% | ▲ +2.11% | $2.51 (−5.46%) |
Oct 7, 2026 19d ago | 8-K | $0.1019 $0.0921 | ▼ −9.62% | ▼ −10.22% | $2.51 (+2363.20%) |
Sep 14, 2026 6w ago | 8-K | $0.1593 $0.1521 | ▼ −4.52% | ▼ −4.06% | $2.51 (+1475.64%) |
Sep 11, 2026 6w ago | 8-K | $0.1626 $0.1593 | ▲ +2.03% | ▲ +1.58% | $2.51 (−1443.67%) |
Sep 10, 2026 6w ago | Press Release | $0.1614 $0.1626 | ▲ +0.74% | ▼ −0.11% | $2.51 (+1455.14%) |
Sep 3, 2026 7w ago | 8-K | $0.1705 $0.1720 | ▲ +0.88% | ▲ +1.27% | $2.51 (+1372.14%) |
Jul 16, 2026 14w ago | Press Release | $0.4060 $0.3758 | ▼ −7.44% | ▼ −6.45% | $2.51 (+518.23%) |
May 14, 2026 23w ago | Press Release | $0.3010 $0.2910 | ▲ +3.32% | ▲ +3.26% | $2.51 (−733.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers